Hypovolumic shock

Reading File
Finding Sources
Finding Sources
Searching PubMed

"hypovolemic shock" management

Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Reading File
Loading Image
I now have comprehensive information to provide a thorough answer on hypovolemic shock. Let me compile everything.

Hypovolemic Shock

Hypovolemic shock is the most common type of shock encountered in surgical and emergency practice. It occurs when intravascular volume falls to a level at which the heart can no longer maintain adequate cardiac output (CO) to meet the oxygen demands of vital organs.

Definition & Core Pathophysiology

Hypovolemic shock is defined by:
  • Reduced CO due to decreased preload (low circulating volume)
  • Elevated SVR (sympathetic compensatory vasoconstriction)
  • Low CVP and PCWP (low filling pressures)
  • Low mixed venous O2 saturation (SvO2)
Harrison's Principles of Internal Medicine 22E summarizes it: "Hypovolemic shock encompasses disease processes that reduce CO (and oxygen delivery) via a reduction in preload... characterized by an elevated SVR and low CVP and PCWP related to decreased intravascular volume."

Causes

Hemorrhagic (most common):
  • External trauma
  • Internal bleeding (upper/lower GI hemorrhage)
Non-hemorrhagic:
  • GI losses: profuse vomiting, diarrhea
  • Renal losses: osmotic diuresis (DKA, diabetes insipidus)
  • Skin losses: severe burns, Stevens-Johnson syndrome
  • Plasma sequestration: soft tissue injury, peritonitis, bowel obstruction
The essential threshold: loss of >20% of circulating volume is required to produce the full shock syndrome. Blood volume is estimated at ~7% of ideal body weight (~4,900 mL in a 70-kg adult).

Compensatory Mechanisms

When blood volume and arterial pressure fall, three major systems are activated:
Cardiovascular responses to hemorrhage - showing baroreceptor reflex, renin-angiotensin-aldosterone activation, and capillary fluid absorption
Fig. Cardiovascular responses to hemorrhage (Costanzo Physiology)
1. Baroreceptor Reflex (immediate):
  • Increased sympathetic outflow
  • Tachycardia + increased contractility
  • Arteriolar constriction → increased TPR
  • Venous constriction → increased venous return
2. Renin-Angiotensin-Aldosterone System:
  • Angiotensin II raises TPR
  • Aldosterone promotes Na+ retention → restores blood volume
3. Capillary Fluid Shift:
  • Decreased capillary hydrostatic pressure draws interstitial fluid into vasculature, restoring volume
Key point: Sympathetic reflexes preferentially maintain arterial pressure over cardiac output - CO falls first, BP falls later. Cardiac and cerebral blood flows are protected until MAP falls below ~70 mmHg.

Effect of Blood Loss on Hemodynamics

Effect of hemorrhage on cardiac output and arterial pressure as percentage of blood volume removed
Fig. Effect of hemorrhage on cardiac output and arterial pressure (Guyton & Hall)
  • Up to ~10% blood loss: minimal change in BP or CO
  • 20-30%: CO begins to fall significantly; BP partially maintained by reflexes
  • 40-45%: Both CO and BP fall to zero - lethal without intervention

ATLS Classification (Hemorrhagic Shock)

ClassBlood LossVolume (70-kg adult)HRBPPulse PressureUrine OutputMental Status
I<15%<750 mLNormalNormalNormal>30 mL/hrNormal
II15-30%750-1,500 mL>100Slightly ↓Narrowed20-30 mL/hrAnxious
III30-40%1,500-2,000 mL>120HypotensiveNarrowed5-15 mL/hrConfused
IV>40%>2,000 mL>140Severely ↓UnobtainableNegligibleLethargic/Comatose
From Mulholland and Greenfield's Surgery / ATLS classification
  • Class I-II: crystalloid resuscitation usually sufficient
  • Class III: blood transfusion + crystalloid
  • Class IV: immediate blood transfusion + surgical/angiographic intervention

Progressive vs. Nonprogressive Shock

Nonprogressive (Compensated) Shock:
  • Blood loss within tolerable limits
  • Compensatory mechanisms (baroreceptors, RAAS, stress-relaxation) maintain circulation
  • Patient can recover with adequate resuscitation
Progressive Shock:
  • Blood loss exceeds a critical threshold (~45% in experimental models)
  • "Shock causes more shock" - a vicious cycle of deterioration
  • Mechanisms include: cardiac ischemia → decreased contractility, gut ischemia → toxin release, microvascular failure, coagulopathy
  • Without intervention, leads to irreversible shock and death
Irreversible Shock:
  • So much cellular and tissue damage that survival is impossible even with aggressive treatment
  • Characterized by refractory hypotension, multiorgan failure

Hemodynamic Profile (Comparison Table)

Shock TypeCOSVRPAOPCVPSvO2
Hypovolemic
Cardiogenic (LV MI)N/↑
Cardiogenic (RV MI)N/↓
Tamponade
Distributive (early)↑/NNN
Source: Mulholland and Greenfield's Surgery
The unique signature of hypovolemic shock: low CO + high SVR + low filling pressures (CVP, PCWP).

Clinical Features

  • Tachycardia (earliest and most sensitive sign)
  • Tachypnea
  • Hypotension (late sign - appears after Class III)
  • Narrowed pulse pressure
  • Cool, pale, clammy skin (cutaneous vasoconstriction)
  • Delayed capillary refill
  • Oliguria/anuria (reduced renal perfusion)
  • Altered mental status (anxiety → confusion → coma)
For non-hemorrhagic hypovolemia (plasma/fluid losses), additional features include:
  • Hemoconcentration
  • Elevated BUN and creatinine
  • Hypernatremia (in free water losses)

Treatment

General Principles:
  1. Stop the source of loss (hemorrhage control, treat underlying cause)
  2. Restore intravascular volume (fluid resuscitation)
  3. Restore oxygen-carrying capacity (blood transfusion when indicated)
Specific Management:
ClassIntervention
IObservation; fluid replacement usually not needed
IICrystalloid (isotonic saline or lactated Ringer's)
IIICrystalloid + packed red blood cells (pRBCs)
IVImmediate blood products + emergent surgical/interventional radiology
Hemorrhagic shock additional considerations:
  • Damage control resuscitation: balanced ratio of pRBCs:FFP:platelets (1:1:1)
  • Permissive hypotension: tolerate MAP 50-65 mmHg until hemorrhage controlled (avoid fluid overload and clot disruption before surgical control)
  • Tranexamic acid (TXA): given within 3 hours of injury to reduce hemorrhage-related mortality
  • Vasopressors: generally NOT first-line; used only if volume replacement is insufficient and patient remains unstable
For non-hemorrhagic losses: crystalloid replacement tailored to the specific electrolyte abnormality (e.g., hypotonic fluids for hypernatremia, repleting specific electrolytes for GI losses).

Monitoring Endpoints

  • Urine output (target >0.5 mL/kg/hr in adults)
  • Lactate clearance (target normalization within 6 hours)
  • Heart rate normalization
  • Mean arterial pressure (target >65 mmHg)
  • CVP/PCWP if central monitoring available
  • Point-of-care ultrasound (POCUS): a recent 2025 systematic review (PMID: 40603759) confirms POCUS has high diagnostic accuracy in differentiating shock types

Key Sources:
  • Guyton and Hall Textbook of Medical Physiology, Ch. 24
  • Mulholland and Greenfield's Surgery, Ch. 9
  • Harrison's Principles of Internal Medicine 22E
  • Costanzo Physiology, 7th Ed., Box 4.3
  • Sabiston Textbook of Surgery
This is a shared conversation. Sign in to Orris to start your own chat.